Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Jazz Pharmaceuticals their estimated

Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Jazz Pharmaceuticals their estimated earnings by 26.89%, reporting an EPS of $4.2 versus an estimate of $3.31, which surprised analysts.

Revenue was up $237,227,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.48, which was followed by a 10.47% drop in the share price the next day.

Here's a look at Jazz Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.